Profile
Joseph T.
Schepers held several positions in investor relations and communications, including Director of Investor Relations at Shionogi Pharma, Director of Investor Relations at Novartis AG, and Executive Director of Investor Relations and Corporate Communications at Chimerix, Inc. He also served as Vice President of Corporate Communications at Artivion, Inc. and Vice President of Investor Relations at Aravive, Inc. Prior to these roles, he was the VP of Corporate Communications and Investor Relations at Bausch Health Americas, Inc. from 2000 to 2003.
Schepers earned an undergraduate degree and an MBA from Seton Hall University.
Former positions of Joseph T. Schepers
Companies | Position | End |
---|---|---|
CHIMERIX, INC. | Investor Relations Contact | - |
PERNIX THERAPEUTICS HOLDINGS INC | Investor Relations Contact | 31/12/2012 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Public Communications Contact | 31/12/2002 |
ARAVIVE, INC. | Investor Relations Contact | - |
NOVARTIS AG | General Counsel | - |
Training of Joseph T. Schepers
Seton Hall University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ARTIVION, INC. | Health Technology |
NOVARTIS AG | Health Technology |
CHIMERIX, INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
Private companies | 3 |
---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
- Stock Market
- Insiders
- Joseph T. Schepers